# West Pharmaceutical Services, Inc. – Consensus ‘buy’ rating and 11.7% Upside Potential

- Link: https://www.directorstalkinterviews.com/west-pharmaceutical-services-inc.consensus-buy-rating-and-11.7-upside-potential/4121145878
- Published: 2024-03-04T13:54:50+00:00
- Author: Charlotte Edwards

**West Pharmaceutical Services, Inc.** with ticker code (WST) now have 7 confirmed
analysts covering the stock with the consensus suggesting a rating of ‘buy’. The
range between the high target price and low target price is between $470.00 and 
$355.00 suggesting an average Analsyt target price of $400.43. Given that the stocks
previous close was at $358.36 this would indicate that there is a potential upside
of 11.7%. The 50 day MA is $363.31 while the 200 day moving average is $366.62. 
The market capitalization for the company is 26.29B. The current share price for
the company is: $358.72 USD

 The potential market cap would be $29,380,723,081 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 45.47, revenue per share of $39.70
and a 11.93% return on assets.

West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the
design and production of technologically advanced, integrated containment and delivery
systems for injectable drugs and healthcare products. The Company operates through
two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary
Products segment offers proprietary packaging, containment solutions, and drug delivery
products, along with analytical lab services and other integrated services and solutions,
primarily to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured
Products segment serves as a fully integrated business, focused on the design, manufacture,
and automated assembly of complex devices, primarily for pharmaceutical, diagnostic,
and medical device customers. This segment manufactures customer-owned components
and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug
delivery systems, as well as consumer products.

Share on:
